Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(17):1288-1299; doi:10.1093/jnci/djh254
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (47)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Lovat, P. E.
Right arrow Articles by Piacentini, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lovat, P. E.
Right arrow Articles by Piacentini, M.
Related Collections
Right arrowEditorial about this Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

ARTICLE

Gangliosides Link the Acidic Sphingomyelinase–Mediated Induction of Ceramide to 12-Lipoxygenase–Dependent Apoptosis of Neuroblastoma in Response to Fenretinide

Penny E. Lovat, Federica Di Sano, Marco Corazzari, Barbara Fazi, Raffaele Perrone Donnorso, Andy D. J. Pearson, Andrew G. Hall, Christopher P. F. Redfern, Mauro Piacentini

Affiliations of authors: Northern Institute for Cancer Research, University of Newcastle upon Tyne, Newcastle upon Tyne, U.K. (PEL, ADJP, AGH, CPFR); Department of Biology, University of Rome, Rome, Italy (FDS, BF, MP); Istituto Nazionale Malattie Infettive–Istituto di Ricovero e Cura a Carattere Scientifico Lazzaro Spallanzani, Rome (MC, MP); The ‘Regina Elena’ National Cancer Institute, Rome (RPD)

Correspondence to: Chris P. F. Redfern, PhD, Northern Institute for Cancer Research, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, U.K. (e-mail: chris.redfern{at}ncl.ac.uk)

Background: The lipid second messenger ceramide, which is generated by acidic and neutral sphingomyelinases or ceramide synthases, is a common intermediate of many apoptotic pathways. Metabolism of ceramide involves several enzymes, including glucosylceramide synthase and GD3 synthase, and results in the formation of gangliosides (GM3, GD3, and GT3), which in turn promote the generation of reactive oxygen species (ROS) and apoptosis. Fenretinide, a retinoic acid derivative, is thought to induce apoptosis via increases in ceramide levels, but the link between ceramide and subsequent apoptosis in neuroblastoma cells is unclear. Methods: SH-SY5Y and HTLA230 neuroblastoma cells were treated with fenretinide in the presence or absence of inhibitors of enzymes important in ceramide metabolism (fumonisin B1, inhibitor of ceramide synthase; desipramine, inhibitor of acidic and neutral sphingomyelinases; and PDMP, inhibitor of glucosylceramide). Small interfering RNAs were used to specifically block acidic sphingomyelinase or GD3 synthase activities. Apoptosis, ROS, and GD3 expression were measured by flow cytometry. Results: In neuroblastoma cells, ROS generation and apoptosis were associated with fenretinide-induced increased levels of ceramide, glucosylceramide synthase activity, GD3 synthase activity, and GD3. Fenretinide also induced increased levels of GD2, a ganglioside derived from GD3. Inhibition of acidic sphingomyelinase but not of neutral sphingomyelinase or ceramide synthase, blocked fenretinide-induced increases in ceramide, ROS, and apoptosis. Exogenous GD3 induced ROS and apoptosis in SH-SY5Y cells but not in SH-SY5Y cells treated with baicalein, a specific 12-lipoxygenase inhibitor. Exogenous GD2 did not induce apoptosis. Conclusions: A novel pathway of fenretinide-induced apoptosis is mediated by acidic sphingomyelinase, glucosylceramide synthase, and GD3 synthase, which may represent targets for future drug development. GD3 may be a key signaling intermediate leading to apoptosis via the activation of 12-lipoxygenase.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Editorial about this Article

Fenretinide Activates a Distinct Apoptotic Pathway
Ethan Dmitrovsky
J Natl Cancer Inst 2004 96: 1264-1265. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
FASEB J.Home page
E. L. Smith and E. H. Schuchman
The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases
FASEB J, October 1, 2008; 22(10): 3419 - 3431.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. E. Lovat, M. Corazzari, J. L. Armstrong, S. Martin, V. Pagliarini, D. Hill, A. M. Brown, M. Piacentini, M. A. Birch-Machin, and C. P.F. Redfern
Increasing Melanoma Cell Death Using Inhibitors of Protein Disulfide Isomerases to Abrogate Survival Responses to Endoplasmic Reticulum Stress
Cancer Res., July 1, 2008; 68(13): 5363 - 5369.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
Y. H. Zeidan, R. W. Jenkins, and Y. A. Hannun
Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway
J. Cell Biol., April 21, 2008; 181(2): 335 - 350.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L. Anding, J. S. Chapman, D. W. Barnett, R. W. Curley Jr., and M. Clagett-Dame
The Unhydrolyzable Fenretinide Analogue 4-Hydroxybenzylretinone Induces the Proapoptotic Genes GADD153 (CHOP) and Bcl-2-Binding Component 3 (PUMA) and Apoptosis that Is Caspase- Dependent and Independent of the Retinoic Acid Receptor
Cancer Res., July 1, 2007; 67(13): 6270 - 6277.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Kraveka, L. Li, Z. M. Szulc, J. Bielawski, B. Ogretmen, Y. A. Hannun, L. M. Obeid, and A. Bielawska
Involvement of Dihydroceramide Desaturase in Cell Cycle Progression in Human Neuroblastoma Cells
J. Biol. Chem., June 8, 2007; 282(23): 16718 - 16728.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Puntoni, S. Zanardi, D. Branchi, S. Bruno, A. Curotto, M. Varaldo, P. Bruzzi, and A. Decensi
Prognostic Effect of DNA Aneuploidy from Bladder Washings in Superficial Bladder Cancer
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 979 - 983.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. H. Zeidan and Y. A. Hannun
Activation of Acid Sphingomyelinase by Protein Kinase C{delta}-mediated Phosphorylation
J. Biol. Chem., April 13, 2007; 282(15): 11549 - 11561.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
R. Vene, G. Arena, A. Poggi, C. D'Arrigo, M. Mormino, D. M. Noonan, A. Albini, and F. Tosetti
Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic implications
Mol. Cancer Ther., January 1, 2007; 6(1): 286 - 298.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Tanno, C. Mancini, R. Vitali, M. Mancuso, H. P. McDowell, C. Dominici, and G. Raschella
Down-Regulation of Insulin-Like Growth Factor I Receptor Activity by NVP-AEW541 Has an Antitumor Effect on Neuroblastoma Cells In vitro and In vivo.
Clin. Cancer Res., November 15, 2006; 12(22): 6772 - 6780.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. Colombo, F. Formelli, M. G. Cantu, G. Parma, M. Gasco, A. Argusti, A. Santinelli, R. Montironi, E. Cavadini, L. Baglietto, et al.
A Phase I-II Preoperative Biomarker Trial of Fenretinide in Ascitic Ovarian Cancer.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1914 - 1919.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Wang, Z. Sun, A. V. Li, and K. J. Yarema
Roles for UDP-GlcNAc 2-Epimerase/ManNAc 6-Kinase outside of Sialic Acid Biosynthesis: MODULATION OF SIALYLTRANSFERASE AND BiP EXPRESSION, GM3 AND GD3 BIOSYNTHESIS, PROLIFERATION, AND APOPTOSIS, AND ERK1/2 PHOSPHORYLATION
J. Biol. Chem., September 15, 2006; 281(37): 27016 - 27028.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Schulz, T. Mousallem, M. Venkataramani, D.-A. Persaud-Sawin, A. Zucker, C. Luberto, A. Bielawska, J. Bielawski, J. C. M. Holthuis, S. M. Jazwinski, et al.
The CLN9 Protein, a Regulator of Dihydroceramide Synthase
J. Biol. Chem., February 3, 2006; 281(5): 2784 - 2794.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Wu, Y. Cheng, B. A. G. Jonsson, A. Nilsson, and R.-D. Duan
Acid sphingomyelinase is induced by butyrate but does not initiate the anticancer effect of butyrate in HT29 and HepG2 cells
J. Lipid Res., September 1, 2005; 46(9): 1944 - 1952.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Z. Wu, R. Tandon, J. Ziembicki, J. Nagano, K. M. Hujer, R. T. Miller, and C. Huang
Role of ceramide in Ca2+-sensing receptor-induced apoptosis
J. Lipid Res., July 1, 2005; 46(7): 1396 - 1404.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Erdreich-Epstein, L. B. Tran, O. T. Cox, E. Y. Huang, W. E. Laug, H. Shimada, and M. Millard
Endothelial apoptosis induced by inhibition of integrins {alpha}v{beta}3 and {alpha}v{beta}5 involves ceramide metabolic pathways
Blood, June 1, 2005; 105(11): 4353 - 4361.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Gouaze, Y.-Y. Liu, C. S. Prickett, J. Y. Yu, A. E. Giuliano, and M. C. Cabot
Glucosylceramide Synthase Blockade Down-Regulates P-Glycoprotein and Resensitizes Multidrug-Resistant Breast Cancer Cells to Anticancer Drugs
Cancer Res., May 1, 2005; 65(9): 3861 - 3867.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. S. Myatt, C. P.F. Redfern, and S. A. Burchill
p38MAPK-Dependent Sensitivity of Ewing's Sarcoma Family of Tumors to Fenretinide-Induced Cell Death
Clin. Cancer Res., April 15, 2005; 11(8): 3136 - 3148.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. M. Poulose, E. D. Harris, and B. S. Patil
Citrus Limonoids Induce Apoptosis in Human Neuroblastoma Cells and Have Radical Scavenging Activity
J. Nutr., April 1, 2005; 135(4): 870 - 877.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Dmitrovsky
Fenretinide Activates a Distinct Apoptotic Pathway
J Natl Cancer Inst, September 1, 2004; 96(17): 1264 - 1265.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.